Breaking News Instant updates and real-time market news.

MD

Mednax

$16.99 /

+0.1 (+0.59%)

06:59
06/05/20
06/05
06:59
06/05/20
06:59

Mednax says operations 'began to normalize in accelerating fashion' in May

As previously disclosed, during the second quarter to date, MEDNAX's operations have been significantly impacted by reductions in patient volumes and revenue as a result of the COVID-19 pandemic. However, the company's operations began to normalize in an accelerating fashion during the month of May. In the company's radiology services medical group, during the month of April, study volumes declined by approximately 50% versus the prior year. On a preliminary basis, the company estimates that study volumes declined by approximately 30%-35% during the month of May, with those declines lessening to approximately 25% by the end of the month. In the company's office-based women's and children's medical groups, during the month of April, patient volumes declined by approximately 25% versus the prior year. On a preliminary basis, the company estimates that during the month of May, patient volumes declined by approximately 10%-15% versus the prior year, with those declines lessening to approximately 10% by the end of the month. Finally, the company estimates that aggregate patient volumes in its hospital-based pediatric medical groups, including neonatology and neonatology-related services, pediatric intensive care, and other pediatric services, experienced only minor, single-digit percentage declines through the months of April and May. In total, the company estimates that the reduction to consolidated revenue as a result of these declines in patient volume during the month of May, as compared to the prior year, was in the range of approximately 10%-15%. During the month of April, the company estimates that this impact was approximately 25%. As previously announced, MEDNAX implemented a number of actions to preserve its financial flexibility and partially mitigate the significant impact of COVID-19 on the company. MEDNAX and its affiliated practices have also received, and expect to receive, certain funds available to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act. Additionally, in recent weeks, following the divestiture of American Anesthesiology on May 6, 2020, MEDNAX has taken action to remove approximately $10M in annualized expenses, and the company believes there are significant additional opportunities to reshape the cost structure of its support services to affiliated practices. Finally, during the month of May, MEDNAX repaid all borrowings on its revolving credit facility. As of May 31, the company's debt consisted solely of $1.75B in senior notes, and MEDNAX had total cash on hand of $90M, resulting in net debt of $1.66B.

  • 05

    Jun

MD Mednax
$16.99 /

+0.1 (+0.59%)

05/29/20 Mizuho
Mednax price target lowered to $17 from $19 at Mizuho
05/08/20 Deutsche Bank
Mednax price target lowered to $15 from $24 at Deutsche Bank
03/26/20 Credit Suisse
Mednax price target lowered to $22 from $29 at Credit Suisse
02/24/20 JPMorgan
Mednax price target lowered to $20 from $33 at JPMorgan

TODAY'S FREE FLY STORIES

General news
FX Action: USD-JPY has lifted back above 104.00 » 05:45
12/04/20
12/04
05:45
12/04/20
05:45

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Mesoblast downgraded to Sell from Neutral at Chardan » 05:44
12/04/20
12/04
05:44
12/04/20
05:44
MESO

Mesoblast

$15.73 /

-0.08 (-0.51%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$15.73 /

-0.08 (-0.51%)

MESO Mesoblast
$15.73 /

-0.08 (-0.51%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
MESO Mesoblast
$15.73 /

-0.08 (-0.51%)

MESO Mesoblast
$15.73 /

-0.08 (-0.51%)

MESO Mesoblast
$15.73 /

-0.08 (-0.51%)

Recommendations
Everi Holdings price target raised to $16 from $12 at BTIG » 05:31
12/04/20
12/04
05:31
12/04/20
05:31
EVRI

Everi Holdings

$13.36 /

+1.955 (+17.15%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVRI Everi Holdings
$13.36 /

+1.955 (+17.15%)

EVRI Everi Holdings
$13.36 /

+1.955 (+17.15%)

09/09/20
Fly Intel: Top five analyst initiations
09/09/20 BTIG
Everi Holdings initiated with a Buy at BTIG
07/10/20 Roth Capital
Everi Holdings initiated with a Buy, $17 target at Roth Capital
06/03/20 Raymond James
Everi Holdings price target lowered to $10 from $14 at Raymond James
EVRI Everi Holdings
$13.36 /

+1.955 (+17.15%)

  • 06
    Dec
EVRI Everi Holdings
$13.36 /

+1.955 (+17.15%)

Upgrade
Silgan Holdings upgraded to Overweight from Equal Weight at Wells Fargo » 05:28
12/04/20
12/04
05:28
12/04/20
05:28
SLGN

Silgan Holdings

$33.98 /

+ (+0.00%)

Wells Fargo analyst Gabe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$33.98 /

+ (+0.00%)

SLGN Silgan Holdings
$33.98 /

+ (+0.00%)

12/03/20 KeyBanc
Silgan Holdings upgraded to Overweight at KeyBanc
12/02/20 KeyBanc
Silgan Holdings upgraded to Overweight from Sector Weight at KeyBanc
11/24/20 BofA
BofA upgrades two, downgrades two in paper & packaging reranking
11/24/20 BofA
Silgan Holdings downgraded to Underperform from Neutral at BofA
SLGN Silgan Holdings
$33.98 /

+ (+0.00%)

Upgrade
Michaels upgraded to Equal Weight from Underweight at Morgan Stanley » 05:27
12/04/20
12/04
05:27
12/04/20
05:27
MIK

Michaels

$12.35 /

+2.08 (+20.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIK Michaels
$12.35 /

+2.08 (+20.25%)

MIK Michaels
$12.35 /

+2.08 (+20.25%)

09/25/20 Loop Capital
Michaels price target raised to $25 from $20 at Loop Capital
09/25/20 Morgan Stanley
Morgan Stanley ups Michaels price target to $7, questions ability to meet goals
09/04/20
Fly Intel: Top five analyst upgrades
09/04/20 JPMorgan
JPMorgan boosts Michaels target to $16, calls selloff 'highly irrational'
MIK Michaels
$12.35 /

+2.08 (+20.25%)

MIK Michaels
$12.35 /

+2.08 (+20.25%)

MIK Michaels
$12.35 /

+2.08 (+20.25%)

MIK Michaels
$12.35 /

+2.08 (+20.25%)

Hot Stocks
Volvo announces commercial availability of VNR Electric model in North America » 05:27
12/04/20
12/04
05:27
12/04/20
05:27
VOLVY

Volvo

$0.00 /

+ (+0.00%)

Volvo Trucks North…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VOLVY Volvo
$0.00 /

+ (+0.00%)

VOLVY Volvo
$0.00 /

+ (+0.00%)

12/01/20 Exane BNP Paribas
Volvo upgraded to Outperform from Neutral at Exane BNP Paribas
11/25/20 HSBC
Volvo upgraded to Buy from Hold at HSBC
09/28/20 Nordea
Volvo upgraded to Buy from Hold at Nordea
09/24/20 Exane BNP Paribas
Volvo downgraded to Neutral from Outperform at Exane BNP Paribas
VOLVY Volvo
$0.00 /

+ (+0.00%)

Upgrade
Waddell & Reed upgraded to Equal Weight from Underweight at Morgan Stanley » 05:27
12/04/20
12/04
05:27
12/04/20
05:27
WDR

Waddell & Reed

$25.59 /

+8.58 (+50.44%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDR Waddell & Reed
$25.59 /

+8.58 (+50.44%)

WDR Waddell & Reed
$25.59 /

+8.58 (+50.44%)

12/03/20 Evercore ISI
Waddell & Reed upgraded to In Line from Underperform at Evercore ISI
10/05/20 Jefferies
Trian involvement could by catalyst for 'beaten down' managers, says Jefferies
07/29/20 Citi
Waddell & Reed upgraded to Neutral following Q2 report at Citi
07/29/20 Citi
Waddell & Reed upgraded to Neutral from Sell at Citi
WDR Waddell & Reed
$25.59 /

+8.58 (+50.44%)

WDR Waddell & Reed
$25.59 /

+8.58 (+50.44%)

WDR Waddell & Reed
$25.59 /

+8.58 (+50.44%)

Downgrade
Bionano Genomics downgraded to Neutral from Buy at Roth Capital » 05:26
12/04/20
12/04
05:26
12/04/20
05:26
BNGO

Bionano Genomics

$0.49 /

+0.005 (+1.02%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNGO Bionano Genomics
$0.49 /

+0.005 (+1.02%)

BNGO Bionano Genomics
$0.49 /

+0.005 (+1.02%)

09/24/20 Ladenburg
Bionano Genomics initiated with a Buy at Ladenburg
04/08/20 Oppenheimer
Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
04/08/20 Oppenheimer
Bionano Genomics initiated with an Outperform at Oppenheimer
BNGO Bionano Genomics
$0.49 /

+0.005 (+1.02%)

Upgrade
Continental Resources upgraded to Buy from Hold at Truist » 05:25
12/04/20
12/04
05:25
12/04/20
05:25
CLR

Continental Resources

$16.06 /

+0.255 (+1.61%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLR Continental Resources
$16.06 /

+0.255 (+1.61%)

CLR Continental Resources
$16.06 /

+0.255 (+1.61%)

11/18/20 Piper Sandler
Continental Resources price target raised to $15 from $13 at Piper Sandler
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
09/14/20 Northland
Continental Resources initiated with a Market Perform at Northland
09/09/20 MKM Partners
Continental Resources upgraded to Buy from Neutral at MKM Partners
CLR Continental Resources
$16.06 /

+0.255 (+1.61%)

CLR Continental Resources
$16.06 /

+0.255 (+1.61%)

CLR Continental Resources
$16.06 /

+0.255 (+1.61%)

Upgrade
Viper Energy upgraded to Buy from Hold at Truist » 05:25
12/04/20
12/04
05:25
12/04/20
05:25
VNOM

Viper Energy

$11.94 /

+0.43 (+3.74%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNOM Viper Energy
$11.94 /

+0.43 (+3.74%)

VNOM Viper Energy
$11.94 /

+0.43 (+3.74%)

07/27/20 Seaport Global
Viper Energy Partners initiated with a Neutral at Seaport Global
07/20/20 Northland
Viper Energy price target raised to $12 from $10 at Northland
07/16/20 Imperial Capital
Viper Energy price target raised to $12 from $10 at Imperial Capital
06/22/20 Goldman Sachs
Diamondback Energy downgraded to Neutral from Buy at Goldman Sachs
VNOM Viper Energy
$11.94 /

+0.43 (+3.74%)

VNOM Viper Energy
$11.94 /

+0.43 (+3.74%)

Hot Stocks
Dada Now partners with cake brands across China, increases order volume by 144% » 05:24
12/04/20
12/04
05:24
12/04/20
05:24
DADA

Dada Nexus

$45.00 /

-8.59 (-16.03%)

Dada Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DADA Dada Nexus
$45.00 /

-8.59 (-16.03%)

DADA Dada Nexus
$45.00 /

-8.59 (-16.03%)

11/11/20
Fly Intel: Top five analyst upgrades
11/11/20 Goldman Sachs
Goldman Sachs upgrades Dada Nexus to Buy on online grocery adoption in China
11/11/20 Goldman Sachs
Dada Nexus upgraded to Buy from Neutral at Goldman Sachs
10/29/20 New Street
Dada Nexus initiated with a Buy at New Street
DADA Dada Nexus
$45.00 /

-8.59 (-16.03%)

  • 03
    Dec
  • 05
    Jun
DADA Dada Nexus
$45.00 /

-8.59 (-16.03%)

Upgrade
BBVA upgraded to Market Perform from Underperform at Keefe Bruyette » 05:24
12/04/20
12/04
05:24
12/04/20
05:24
BBVA

BBVA

$4.89 /

-0.08 (-1.61%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBVA BBVA
$4.89 /

-0.08 (-1.61%)

BBVA BBVA
$4.89 /

-0.08 (-1.61%)

11/30/20 Stephens
PNC Financial downgraded to Equal Weight from Overweight at Stephens
11/27/20 BofA
BBVA upgraded to Neutral at BofA after Banco Sabadell merger called off
11/27/20 BofA
BBVA upgraded to Neutral from Underperform at BofA
11/24/20 Morgan Stanley
BBVA price target raised to EUR 4 from EUR 2.90 at Morgan Stanley
BBVA BBVA
$4.89 /

-0.08 (-1.61%)

BBVA BBVA
$4.89 /

-0.08 (-1.61%)

BBVA BBVA
$4.89 /

-0.08 (-1.61%)

Upgrade
Cracker Barrel upgraded to Outperform from Market Perform at Telsey Advisory » 05:23
12/04/20
12/04
05:23
12/04/20
05:23
CBRL

Cracker Barrel

$144.73 /

+3.08 (+2.17%)

Telsey Advisory analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBRL Cracker Barrel
$144.73 /

+3.08 (+2.17%)

CBRL Cracker Barrel
$144.73 /

+3.08 (+2.17%)

11/17/20 CL King
Cracker Barrel price target raised to $155 from $140 at CL King
10/12/20
CL King upgrades Cracker Barrel to Buy on accelerating comps
10/12/20 CL King
Cracker Barrel upgraded to Buy from Neutral at CL King
09/16/20 Wells Fargo
Cracker Barrel price target raised to $132 from $116 at Wells Fargo
CBRL Cracker Barrel
$144.73 /

+3.08 (+2.17%)

Upgrade
Croda International upgraded to Outperform from Underperform at Credit Suisse » 05:21
12/04/20
12/04
05:21
12/04/20
05:21
COIHY

Croda International

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COIHY Croda International
$0.00 /

+ (+0.00%)

11/27/20 Deutsche Bank
Croda price target raised to EUR 6,500 from EUR 5,700 at Deutsche Bank
11/20/20 Citi
Croda International upgraded to Buy from Neutral at Citi
11/17/20 Deutsche Bank
Croda price target raised to 5,700 GBp from 4,700 GBp at Deutsche Bank
11/12/20 Barclays
Croda downgraded to Underweight from Equal Weight at Barclays
Upgrade
Royal Unibrew upgraded to Buy from Hold at Danske Bank » 05:21
12/04/20
12/04
05:21
12/04/20
05:21
ROYUF

Royal Unibrew

$0.00 /

+ (+0.00%)

Danske Bank analyst Jonas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROYUF Royal Unibrew
$0.00 /

+ (+0.00%)

10/23/20 Citi
Royal Unibrew initiated with a Buy at Citi
10/07/20 Jefferies
Royal Unibrew downgraded to Hold from Buy at Jefferies
08/24/20 Deutsche Bank
Royal Unibrew price target raised to DKK 690 from DKK 560 at Deutsche Bank
08/20/20 JPMorgan
Royal Unibrew price target raised to DKK 540 from DKK 465 at JPMorgan
Upgrade
Workspace Group upgraded to Buy from Hold at Panmure Gordon » 05:20
12/04/20
12/04
05:20
12/04/20
05:20
WKPPF

Workspace Group

$0.00 /

+ (+0.00%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WKPPF Workspace Group
$0.00 /

+ (+0.00%)

11/20/20 BofA
Workspace Group downgraded to Neutral from Buy at BofA
Upgrade
Hyve Group upgraded to Buy from Add at Peel Hunt » 05:19
12/04/20
12/04
05:19
12/04/20
05:19
ITEPF

Hyve Group

$0.00 /

+ (+0.00%)

Peel Hunt analyst Malcolm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITEPF Hyve Group
$0.00 /

+ (+0.00%)

08/03/20 Citi
Hyve Group Buy rating affirmed at Citi
06/09/20 Liberum
Hyve Group initiated with a Hold at Liberum
05/11/20 Peel Hunt
Hyve Group upgraded to Buy from Hold at Peel Hunt
Hot Stocks
Celyad doses first patient in IMMUNICY-1 trial of CYAD-211 » 05:18
12/04/20
12/04
05:18
12/04/20
05:18
CYAD

Celyad

$9.20 /

-0.45 (-4.66%)

Celyad announced dosing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYAD Celyad
$9.20 /

-0.45 (-4.66%)

CYAD Celyad
$9.20 /

-0.45 (-4.66%)

03/26/20 Wells Fargo
Celyad price target lowered to $20 from $44 at Wells Fargo
03/25/20 H.C. Wainwright
Celyad price target lowered to $37 from $43 at H.C. Wainwright
Upgrade
Aryzta upgraded to Buy from Add at Baader Helvea » 05:17
12/04/20
12/04
05:17
12/04/20
05:17
ARZTY

Aryzta

$0.00 /

+ (+0.00%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARZTY Aryzta
$0.00 /

+ (+0.00%)

10/27/20 AlphaValue
Aryzta downgraded to Add from Buy at AlphaValue
09/23/20 Kepler Cheuvreux
Aryzta initiated with a Reduce at Kepler Cheuvreux
06/01/20 UBS
Aryzta price target lowered to CHF 0.65 from CHF 0.95 at UBS
ARZTY Aryzta
$0.00 /

+ (+0.00%)

Upgrade
Sage Therapeutics upgraded to Buy from Neutral at Mizuho » 05:15
12/04/20
12/04
05:15
12/04/20
05:15
SAGE

Sage Therapeutics

$69.89 /

+1.25 (+1.82%)

, BIIB

Biogen

$244.04 /

-3.21 (-1.30%)

Mizuho analyst Vamil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$69.89 /

+1.25 (+1.82%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

SAGE Sage Therapeutics
$69.89 /

+1.25 (+1.82%)

12/01/20
Fly Intel: Top five analyst downgrades
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
12/01/20 Citi
Sage Therapeutics price target lowered to $93 from $100 at Citi
BIIB Biogen
$244.04 /

-3.21 (-1.30%)

12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
12/01/20 Citi
Sage Therapeutics price target lowered to $93 from $100 at Citi
12/01/20 RBC Capital
Biogen price target raised to $256 from $249 at RBC Capital
SAGE Sage Therapeutics
$69.89 /

+1.25 (+1.82%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

SAGE Sage Therapeutics
$69.89 /

+1.25 (+1.82%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

BIIB Biogen
$244.04 /

-3.21 (-1.30%)

Hot Stocks
Clover announces data for COVID-19 S-Trimer vaccine candidates » 05:14
12/04/20
12/04
05:14
12/04/20
05:14
GSK

GlaxoSmithKline

$37.27 /

-0.14 (-0.37%)

, DVAX

Dynavax

$5.18 /

-0.065 (-1.24%)

Clover Biopharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

DVAX Dynavax
$5.18 /

-0.065 (-1.24%)

GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

12/03/20
Fly Intel: Top five analyst downgrades
12/03/20 UBS
GlaxoSmithKline downgraded to Neutral from Buy at UBS
11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
DVAX Dynavax
$5.18 /

-0.065 (-1.24%)

11/06/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
08/07/20 H.C. Wainwright
Dynavax price target lowered to $12 from $14 at H.C. Wainwright
08/03/20 H.C. Wainwright
Dynavax price target raised to $14 from $12 at H.C. Wainwright
07/16/20 William Blair
Dynavax has 'attractive asset' in CpG 1018, says William Blair
GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

DVAX Dynavax
$5.18 /

-0.065 (-1.24%)

  • 22
    May
GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

DVAX Dynavax
$5.18 /

-0.065 (-1.24%)

GSK GlaxoSmithKline
$37.27 /

-0.14 (-0.37%)

DVAX Dynavax
$5.18 /

-0.065 (-1.24%)

Downgrade
Ipsen downgraded to Neutral from Buy at BofA » 05:12
12/04/20
12/04
05:12
12/04/20
05:12
IPSEY

Ipsen

$0.00 /

+ (+0.00%)

BofA analyst Sachin Jain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IPSEY Ipsen
$0.00 /

+ (+0.00%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

12/02/20 Bryan Garnier
Ipsen downgraded to Neutral from Buy at Bryan Garnier
10/26/20 Barclays
Ipsen upgraded to Overweight from Equal Weight at Barclays
10/20/20 Kepler Cheuvreux
Ipsen upgraded to Hold from Reduce at Kepler Cheuvreux
09/21/20 Kepler Cheuvreux
Ipsen downgraded to Reduce from Hold at Kepler Cheuvreux
Downgrade
Lloyds Banking downgraded to Underperform from Neutral at BofA » 05:11
12/04/20
12/04
05:11
12/04/20
05:11
LYG

Lloyds Banking

$2.07 /

+0.04 (+1.97%)

BofA analyst Rohith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LYG Lloyds Banking
$2.07 /

+0.04 (+1.97%)

LYG Lloyds Banking
$2.07 /

+0.04 (+1.97%)

12/02/20 Deutsche Bank
Lloyds Banking price target raised to 35 GBp from 32 GBp at Deutsche Bank
11/24/20 Morgan Stanley
Lloyds Banking price target raised to 45 GBp from 40 GBp at Morgan Stanley
11/24/20 HSBC
Lloyds Banking downgraded to Hold from Buy at HSBC
11/24/20 HSBC
Lloyds Banking downgraded to Hold from Buy at HSBC
LYG Lloyds Banking
$2.07 /

+0.04 (+1.97%)

Recommendations
Cooper Companies price target raised to $370 from $351 at Piper Sandler » 05:09
12/04/20
12/04
05:09
12/04/20
05:09
COO

Cooper Companies

$338.74 /

+4.485 (+1.34%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$338.74 /

+4.485 (+1.34%)

COO Cooper Companies
$338.74 /

+4.485 (+1.34%)

11/20/20 Wells Fargo
Cooper Companies price target raised to $380 from $360 at Wells Fargo
09/17/20 Raymond James
Cooper Companies price target raised to $375 from $330 at Raymond James
09/04/20 KeyBanc
Cooper Companies price target raised to $349 from $330 at KeyBanc
09/04/20 JPMorgan
Cooper Companies price target raised to $315 from $285 at JPMorgan
COO Cooper Companies
$338.74 /

+4.485 (+1.34%)

COO Cooper Companies
$338.74 /

+4.485 (+1.34%)

Hot Stocks
EchoStar Mobile partners with JT on hybrid network capability across Europe, UK » 05:08
12/04/20
12/04
05:08
12/04/20
05:08
SATS

EchoStar

$23.65 /

+0.145 (+0.62%)

EchoStar Mobile announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SATS EchoStar
$23.65 /

+0.145 (+0.62%)

SATS EchoStar
$23.65 /

+0.145 (+0.62%)

04/14/20 Citi
EchoStar price target lowered to $36 from $45 at Citi
SATS EchoStar
$23.65 /

+0.145 (+0.62%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.